Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TPE:1720'
s FCF Margin % Range Over the Past 10 Years
Min: 0.52 Med: 11.69 Max: 17.99
Current: 16.77
During the past 13 years, the highest FCF Margin % of Standard Chemical & Pharmaceutical Co was 17.99%. The lowest was 0.52%. And the median was 11.69%.
TPE:1720's FCF Margin % is ranked better than 84.46% of 959
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs TPE:1720: 16.77
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co FCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Standard Chemical & Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Standard Chemical & Pharmaceutical Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Standard Chemical & Pharmaceutical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Standard Chemical & Pharmaceutical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co (TPE:1720) has a FCF Margin % of 5.29% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. This is 55% below median its historical median of 11.69. Over the past decade, Standard Chemical & Pharmaceutical Co's FCF Margin % has ranged from 0.52 to 17.99. According to the industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #149 out of 959 companies in the Drug Manufacturers industry, placing it in the top 15.5%.
Is Standard Chemical & Pharmaceutical Co's FCF Margin % too high?
Standard Chemical & Pharmaceutical Co's current FCF Margin % of 5.29% is 55% below median its 10-year median of 11.69. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 17.99. The Drug Manufacturers industry median FCF Margin % is 2.51. Standard Chemical & Pharmaceutical Co's value of 5.29% is 110.8% above this industry median. Based on the distribution chart, Standard Chemical & Pharmaceutical Co ranks #149 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Standard Chemical & Pharmaceutical Co has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Standard Chemical & Pharmaceutical Co's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #149 out of 959 companies for FCF Margin %. This places Standard Chemical & Pharmaceutical Co in the top 16% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Standard Chemical & Pharmaceutical Co's value of 5.29% is 110.8% above this benchmark. Historically, Standard Chemical & Pharmaceutical Co's own FCF Margin % has ranged from 0.52 to 17.99 over the past decade. While the company's 10-year median is 11.69 vs. the industry median of 2.51, Standard Chemical & Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Standard Chemical & Pharmaceutical Co's current FCF Margin % of 5.29% is 110.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Standard Chemical & Pharmaceutical Co's current FCF Margin % is 5.29%, which is 55% below median its own 10-year median of 11.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard Chemical & Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co (TPE:1720) is currently considered Fairly Valued. The stock's GF Value™ is NT$58.91, compared to a current price of NT$57.20 — trading 2.9% below its estimated fair value. The current FCF Margin % is 5.29%, which is 55% below median its 10-year median of 11.69 and 110.8% above the Drug Manufacturers industry median of 2.51. Standard Chemical & Pharmaceutical Co's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Standard Chemical & Pharmaceutical Co (TPE:1720), the current FCF Margin % is 5.29% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Standard Chemical & Pharmaceutical Co (TPE:1720) Overvalued in 2026?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$57.20 is trading 2.9% below its estimated GF Value™ of NT$58.91.
GuruFocus considers Standard Chemical & Pharmaceutical Co to be Fairly Valued.
Key valuation signals for TPE:1720:
FCF Margin %: 5.29% (55% below median its 10-year median of 11.69)
GF Value™: NT$58.91 vs. price of NT$57.20 (2.9% below fair value)
Industry Position: 110.8% above the Drug Manufacturers median (#149 of 959)
No single metric tells the full story. See the TPE:1720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Standard Chemical & Pharmaceutical Co Ltd is engaged in the manufacturing and sales of Chinese and western medicine, cosmetics, beverage, normal instruments and medical instruments. Its segments include Medicine, Dietary supplement and Ingredients. The majority of the revenue is derived from the Medicine segment. Geographically it operates in Taiwan, Japan and Others with Taiwan generating the maximum revenue.
93GF Score
Get the complete analysis for TPE:1720
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1720 has been successfully added to your 
